These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24508075)

  • 1. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.
    Varga N; Sutkeviciute I; Ribeiro-Viana R; Berzi A; Ramdasi R; Daghetti A; Vettoretti G; Amara A; Clerici M; Rojo J; Fieschi F; Bernardi A
    Biomaterials; 2014 Apr; 35(13):4175-84. PubMed ID: 24508075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
    Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
    Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannosylcalix[n]arenes as multivalent ligands for DC-SIGN.
    Morbioli I; Porkolab V; Magini A; Casnati A; Fieschi F; Sansone F
    Carbohydr Res; 2017 Dec; 453-454():36-43. PubMed ID: 29121497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
    Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
    Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
    Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
    ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
    Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
    AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
    Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.
    Arnáiz B; Martínez-Ávila O; Falcon-Perez JM; Penadés S
    Bioconjug Chem; 2012 Apr; 23(4):814-25. PubMed ID: 22433013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
    Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
    J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
    Ramos-Soriano J; Rojo J
    Chem Commun (Camb); 2021 May; 57(42):5111-5126. PubMed ID: 33977972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
    Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond attachment: Roles of DC-SIGN in dengue virus infection.
    Liu P; Ridilla M; Patel P; Betts L; Gallichotte E; Shahidi L; Thompson NL; Jacobson K
    Traffic; 2017 Apr; 18(4):218-231. PubMed ID: 28128492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.
    Lozach PY; Burleigh L; Staropoli I; Navarro-Sanchez E; Harriague J; Virelizier JL; Rey FA; Desprès P; Arenzana-Seisdedos F; Amara A
    J Biol Chem; 2005 Jun; 280(25):23698-708. PubMed ID: 15855154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
    Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface.
    Porkolab V; Pifferi C; Sutkeviciute I; Ordanini S; Taouai M; Thépaut M; Vivès C; Benazza M; Bernardi A; Renaudet O; Fieschi F
    Org Biomol Chem; 2020 Jul; 18(25):4763-4772. PubMed ID: 32608454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.
    Bertolotti B; Sutkeviciute I; Ambrosini M; Ribeiro-Viana R; Rojo J; Fieschi F; Dvořáková H; Kašáková M; Parkan K; Hlaváčková M; Nováková K; Moravcová J
    Org Biomol Chem; 2017 May; 15(18):3995-4004. PubMed ID: 28443908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN.
    Boggiano C; Manel N; Littman DR
    J Virol; 2007 Mar; 81(5):2519-23. PubMed ID: 17182696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.